Lucely Cetina-Pérez, Alberto Serrano-Olvera, Laura Flores-Cisneros, Roberto Jiménez-Lima, Cristina Alvarado-Silva, María Del Consuelo Díaz-Romero, Flavia Morales-Vásquez, David Eduardo Muñoz-González, Aida Mota-García, Oscar Armando Chávez-Fierro, Silvia Cristina Jaramillo-Manzur, Jaime de la Garza-Salazar, Denisse Castro-Eguiluz, Abelardo Meneses-García
Mexico has seen an increase in cancer prevalence in its entire population as well as particular age ranges, predominantly the older segment. The most frequently reported pelvic cancers in Mexico are cervical, endometrial, bladder, prostate, rectum, and anal canal. Approximately 80% of the population diagnosed with pelvic cancers present with locally advanced tumors and require concomitant chemoradiotherapy, sequential chemoradiotherapy, or radiotherapy alone. The toxicity of any of these treatment modalities may be manifested as intestinal injury, a significant problem that can compromise the response to treatment, the patient's nutritional state, quality of life, and survival...
2018: Revista de Investigación Clínica; Organo del Hospital de Enfermedades de la Nutrición